FIA
PRVL

FNY Investment Advisers’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

FNY Investment Advisers’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-600
Closed -$7K – 1228
2019
Q2 		$7K Buy
+600
New +$7K ﹤0.01% 635